Claudin 18.2-directed Antibody Interactions [MoA] - N0000194106

Name: Table of NDC products with claudin 18.2-directed antibody interactions
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000194106
Pharmacologic Name	Claudin 18.2-directed Antibody Interactions
Pharmacologic Uses	claudin 18.2-directed cytolytic antibody
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Claudin 18.2-directed Antibody Interactions

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Claudin 18.2-directed Antibody Interactions [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0469-3425	Vyloy	Non-Proprietary Name: Zolbetuximab	Injection, Powder, For Suspension	Intravenous	Astellas Pharma Us, Inc.	ACTIVE
	0469-4425	Vyloy	Non-Proprietary Name: Zolbetuximab	Injection, Powder, For Suspension	Intravenous	Astellas Pharma Us, Inc.	ACTIVE